(ADIL) Adial Pharmaceuticals - Performance -68.8% in 12m
ADIL performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-89.08%
#182 in Peer-Group
Rel. Strength
4.95%
#7295 in Stock-Universe
Total Return 12m
-68.78%
#175 in Peer-Group
Total Return 5y
-99.09%
#189 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 1.31 USD |
| 52 Week Low | 0.23 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 41.97 |
| Buy/Sell Signal +-5 | -0.95 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ADIL (-68.8%) vs XLV (-4.6%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
3.27% | 140% | 332% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
4.24% | 16.8% | 78.4% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
1.94% | -14.1% | 396% | 63.3 | 35.6 | 1.19 | 58.2% | 18.9% |
| NOVN SW Novartis |
0.79% | 3.78% | 49.4% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-6.42% | 2.63% | 46.3% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-4.86% | -7.48% | 108% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| AZN NASDAQ AstraZeneca |
-4.86% | -8.38% | 44% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
| IPN PA Ipsen |
-2.2% | -6.85% | 38.7% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: ADIL vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for ADIL
| Total Return (including Dividends) | ADIL | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -51.06% | 2.14% | 5.25% |
| 3 Months | -48.37% | 0.64% | 24.13% |
| 12 Months | -68.78% | -4.57% | 14.15% |
| 5 Years | -99.09% | 42.89% | 111.83% |
| Trend Score (consistency of price movement) | ADIL | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -59% | 35.8% | 81% |
| 3 Months | -75.8% | -28.5% | 96.9% |
| 12 Months | -80.7% | -74.5% | 44.9% |
| 5 Years | -91.7% | 87.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th0.50 | -52.09% | -53.50% |
| 3 Month | %th2.50 | -48.69% | -58.40% |
| 12 Month | %th13.00 | -67.28% | -72.65% |
| 5 Years | %th5.00 | -99.36% | -99.57% |
FAQs
Does Adial Pharmaceuticals (ADIL) outperform the market?
No,
over the last 12 months ADIL made -68.78%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.57%.
Over the last 3 months ADIL made -48.37%, while XLV made 0.64%.
Performance Comparison ADIL vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ADIL vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.2% | -56.3% | -75.4% | -83% |
| US NASDAQ 100 | QQQ | -3.9% | -56.4% | -76% | -82% |
| German DAX 40 | DAX | -2% | -49.7% | -87.5% | -98% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4% | -54.3% | -78.8% | -89% |
| Hongkong Hang Seng | HSI | -3.8% | -57.1% | -94.8% | -107% |
| India NIFTY 50 | INDA | -2.3% | -54.5% | -75.7% | -68% |
| Brasil Bovespa | EWZ | -6.6% | -59.9% | -100.4% | -79% |
ADIL vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2.8% | -57% | -79.5% | -93% |
| Consumer Discretionary | XLY | -3.7% | -54.2% | -67.7% | -87% |
| Consumer Staples | XLP | -4.5% | -51.7% | -77% | -78% |
| Energy | XLE | -4.5% | -58.1% | -71.3% | -69% |
| Financial | XLF | -4.9% | -56.1% | -80.3% | -99% |
| Health Care | XLV | -3.6% | -53.2% | -68% | -64% |
| Industrial | XLI | -4.2% | -55.3% | -83.2% | -94% |
| Materials | XLB | -6.4% | -55.3% | -79.9% | -75% |
| Real Estate | XLRE | -4.1% | -52% | -75.1% | -82% |
| Technology | XLK | -4.9% | -59.8% | -77.7% | -80% |
| Utilities | XLU | -3.1% | -52.9% | -78.6% | -92% |
| Aerospace & Defense | XAR | -2% | -58.1% | -93.9% | -118% |
| Biotech | XBI | -5.1% | -54.4% | -62.2% | -62% |
| Homebuilder | XHB | -6.7% | -58.1% | -68.2% | -74% |
| Retail | XRT | -6.7% | -56.1% | -71.1% | -80% |
ADIL vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -5.1% | -59.5% | -67.0% | -61% |
| Natural Gas | UNG | 5.4% | -41.2% | -58.6% | -67% |
| Gold | GLD | -4.4% | -49.9% | -96% | -108% |
| Silver | SLV | -5.2% | -58% | -92.7% | -86% |
| Copper | CPER | -3.2% | -55.7% | -92.4% | -80% |
ADIL vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -2.3% | -52.1% | -71.9% | -67% |
| iShares High Yield Corp. Bond | HYG | -3% | -52.7% | -74.3% | -79% |